David A. Siegel Compugen LTD Transaction History

Two Sigma Advisers, LP

$47 Billion
Q3 2025

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Compugen LTD stock. As of the latest transaction made, Two Sigma Advisers, LP holds 257,784 shares of CGEN stock, worth $433,077. This represents 0.0% of its overall portfolio holdings.

Number of Shares

257,784

Previous 163,484 57.68%

Holding current value

$433,077

Previous $291,000 27.49%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$1.33 - $1.76 $125,419 - $165,968	94,300 Added 57.68%	257,784 $371,000
Q2 2025 Aug 14, 2025	BUY	$1.18 - $1.79 $67,614 - $102,567	57,300 Added 53.96%	163,484 $291,000
Q1 2025 May 15, 2025	BUY	$1.46 - $2.57 $102,784 - $180,928	70,400 Added 196.74%	106,184 $155,000
Q4 2024 Feb 14, 2025	BUY	$1.41 - $1.93 $24,393 - $33,389	17,300 Added 93.59%	35,784 $54,000
Q3 2024 Nov 14, 2024	BUY	$1.56 - $2.1 $28,835 - $38,816	18,484 New	18,484 $33,000

Q1 2024 May 15, 2024	SELL	$1.75 - $2.95 $139,475 - $235,115	-79,700 Reduced 37.4%	133,384 $344,000
Q4 2023 Feb 14, 2024	SELL	$0.53 - $2.0 $43,935 - $165,794	-82,897 Reduced 28.01%	213,084 $421,000
Q3 2023 Nov 14, 2023	SELL	$0.88 - $1.31 $67,410 - $100,349	-76,603 Reduced 20.56%	295,981 $275,000
Q2 2023 Aug 14, 2023	SELL	$0.57 - $1.38 $122,414 - $296,371	-214,762 Reduced 36.56%	372,584 $424,000
Q1 2023 May 15, 2023	SELL	$0.68 - $1.11 $360,901 - $589,119	-530,738 Reduced 47.47%	587,346 $411,000
Q4 2022 Feb 14, 2023	SELL	$0.58 - $1.2 $131,370 - $271,800	-226,500 Reduced 16.85%	1,118,084 $805,000
Q3 2022 Nov 14, 2022	BUY	$0.66 - $2.32 $794,574 - $2.79 Million	1,203,900 Added 855.75%	1,344,584 $883,000
Q2 2022 Aug 15, 2022	BUY	$1.57 - $3.33 $60,288 - $127,872	38,400 Added 37.54%	140,684 $260,000
Q1 2022 May 16, 2022	SELL	$2.76 - $4.64 $87,492 - $147,088	-31,700 Reduced 23.66%	102,284 $329,000
Q4 2021 Feb 14, 2022	BUY	$4.09 - $7.16 $85,890 - $150,360	21,000 Added 18.59%	133,984 $576,000
Q3 2021 Nov 15, 2021	BUY	$5.8 - $8.02 $313,780 - $433,882	54,100 Added 91.88%	112,984 $675,000
Q2 2021 Aug 16, 2021	SELL	$6.87 - $9.16 $399,147 - $532,196	-58,100 Reduced 49.66%	58,884 $488,000
Q1 2021 May 17, 2021	BUY	$7.67 - $13.77 $819,033 - $1.47 Million	106,784 Added 1046.9%	116,984 $1.01 Million
Q4 2020 Feb 16, 2021	BUY	$12.07 - $17.95 $123,114 - $183,090	10,200 New	10,200 $124,000

Others Institutions Holding CGEN

# of Institutions

Shares Held

13.7M

Call Options Held

15.2K

Put Options Held

41.3K

View Full List

About COMPUGEN LTD

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $146M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

More about CGEN

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account